177 related articles for article (PubMed ID: 23024033)
21. Diabetes and risk of prostate cancer in a prospective cohort of US men.
Rodriguez C; Patel AV; Mondul AM; Jacobs EJ; Thun MJ; Calle EE
Am J Epidemiol; 2005 Jan; 161(2):147-52. PubMed ID: 15632264
[TBL] [Abstract][Full Text] [Related]
22. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.
Zhu Z; Zhang X; Shen Z; Zhong S; Wang X; Lu Y; Xu C
PLoS One; 2013; 8(2):e56662. PubMed ID: 23437204
[TBL] [Abstract][Full Text] [Related]
24. Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
Larsson SC; Orsini N; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(22):1679-87. PubMed ID: 16288121
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study.
Tripathi A; Folsom AR; Anderson KE;
Cancer; 2002 Dec; 95(11):2316-23. PubMed ID: 12436437
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.
Zhang F; Yang Y; Skrip L; Hu D; Wang Y; Wong C; Qiu J; Lei H
Acta Diabetol; 2012 Dec; 49 Suppl 1():S235-46. PubMed ID: 23124624
[TBL] [Abstract][Full Text] [Related]
27. Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis.
Schulze MB; Schulz M; Heidemann C; Schienkiewitz A; Hoffmann K; Boeing H
Arch Intern Med; 2007 May; 167(9):956-65. PubMed ID: 17502538
[TBL] [Abstract][Full Text] [Related]
28. Dietary soy and increased risk of bladder cancer: a prospective cohort study of men in Shanghai, China.
Sun CL; Yuan JM; Wang XL; Gao YT; Ross RK; Yu MC
Int J Cancer; 2004 Nov; 112(2):319-23. PubMed ID: 15352046
[TBL] [Abstract][Full Text] [Related]
29. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults.
Coughlin SS; Calle EE; Teras LR; Petrelli J; Thun MJ
Am J Epidemiol; 2004 Jun; 159(12):1160-7. PubMed ID: 15191933
[TBL] [Abstract][Full Text] [Related]
31. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
Tseng CH
BJU Int; 2012 Sep; 110(5):668-73. PubMed ID: 22300458
[TBL] [Abstract][Full Text] [Related]
32. Risk of type 2 diabetes in patients with insomnia: A population-based historical cohort study.
Lin CL; Chien WC; Chung CH; Wu FL
Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28834008
[TBL] [Abstract][Full Text] [Related]
33. Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Eur J Clin Invest; 2014 Aug; 44(8):736-42. PubMed ID: 24931333
[TBL] [Abstract][Full Text] [Related]
34. Observational follow-up of the PROactive study: a 6-year update.
Erdmann E; Song E; Spanheimer R; van Troostenburg de Bruyn AR; Perez A
Diabetes Obes Metab; 2014 Jan; 16(1):63-74. PubMed ID: 23859428
[TBL] [Abstract][Full Text] [Related]
35. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Wahlqvist ML; Lee MS; Hsu CC; Chuang SY; Lee JT; Tsai HN
Parkinsonism Relat Disord; 2012 Jul; 18(6):753-8. PubMed ID: 22498320
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women.
Holick CN; Giovannucci EL; Stampfer MJ; Michaud DS
Int J Cancer; 2007 Jan; 120(1):140-6. PubMed ID: 17036323
[TBL] [Abstract][Full Text] [Related]
37. Human insulin does not increase bladder cancer risk.
Tseng CH
PLoS One; 2014; 9(1):e86517. PubMed ID: 24466131
[TBL] [Abstract][Full Text] [Related]
38. Bladder Cancer In Patients With Type 2 Diabetes Treated With Pioglitazone, A Comparative Study.
Riaz A; Khan K; Afreen B; Kazmi I
J Ayub Med Coll Abbottabad; 2018; 30(3):356-359. PubMed ID: 30465366
[TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.
Xu X; Wu J; Mao Y; Zhu Y; Hu Z; Xu X; Lin Y; Chen H; Zheng X; Qin J; Xie L
PLoS One; 2013; 8(3):e58079. PubMed ID: 23472134
[TBL] [Abstract][Full Text] [Related]
40. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies.
Wu J; Xun P; Tang Q; Cai W; He K
Nutr J; 2017 Sep; 16(1):60. PubMed ID: 28927411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
